Melanotan 2 Research: What the Studies Found
What has Melanotan 2 research found? In people, two small early trials saw skin darken and erections appear. Animal studies over four decades asked wider questions, and their results can't tell you how your own body would respond. Later case reports described harm in people who used it outside any study. You'll see amounts named on this page. They come from those papers, and they are not advice for you.
Melanotan II Mechanism of Action: what it switches on
How can one drug touch your skin, your hunger and your sex drive? Picture MT-II as a key that fits four different locks on the surface of your cells. Scientists call those locks receptors. On this site you'll see them called switches. Each switch sits in different parts of your body, so each one runs a different job.
The skin switch sits on your pigment-making cells. When MT-II turns it on, a chain of messages inside the cell starts the making of dark pigment, and no sunlight is needed. That matches what Dorr saw in 1996, when the men's skin darkened after their shots [1].
The sex-drive switch sits in your brain and helps run both appetite and sexual response. MT-II also reaches the nerves that carry those messages out to your body. In mice, turning this switch on changed how muscle handled sugar. The muscle cells made more of the instructions for a protein that carries sugar inside [12].
The appetite switch also helps govern eating. In a 2022 study in mice, researchers placed a very small dose of MT-II, between 0.1 and 1 nanomole, into one small brain area. A nanomole is a lab measure for an amount far too small for you to see. The mice ate less at 1, 2 and 4 hours afterward [6]. They also put in less effort to reach food. They didn't shun a taste paired with the drug, which suggests they weren't feeling sick. How fast their bodies burned energy didn't change.
The ring shape is why MT-II lasts. In rat blood the natural hormone is gone in about ~10–15 minutes, while the ring breaks down more slowly.
What each MT-2 peptide body switch does
Each of the MT-2 peptide (Melanotan 2) switches does a different job. Once you know the four jobs, you can see why the drug has so many effects.
The skin switch sits on your pigment cells, on the skin cells around them, and on immune cells, your body's germ fighters. Turning it on makes dark pigment. It may also calm swelling in tissue. In some people it may push an existing mole to grow.
The appetite switch sits in parts of the brain that manage hunger and the pleasure of eating. It helps set how much an animal eats. In 2022, Eliason tied this switch to how hard mice would work for food [6].
The sex-drive switch matters most for what MT-II does beyond tanning. It sits in your brain and down your spinal cord. It helps run hunger, sexual response, body heat, and the work your body does without your thinking about it. Several studies saw effects through this switch: the erection trials of 1998 and 2000 [2][3], a 2022 brain-scan study of sexual desire [11], and a 2017 rat study of body weight [5].
The gland switch helps glands in your skin release oil and other fluids. It has had the least study.
MT-II flips all four. Afamelanotide, a cousin drug, mostly flips the skin switch, and bremelanotide, another cousin, mostly flips the sex-drive switch.
That wide reach is why MT-II draws both interest and worry.
Which of the four switches Melanotan 2 uses for each effect
Which switch does what? The skin switch drives your color. The appetite switch helps balance eating and energy. The sex-drive switch runs sexual response, hunger and your body's automatic work. In the studies cited here, it seems to be the one behind both the erections and the lower food intake [2][3][5][6]. The gland switch helps your glands release fluids.
What the two small human trials found
Only two sets of human trials make up the formal record for Melanotan 2. You'd want far more than that before judging help or harm.
In 1996, Dorr started the human tanning work with three healthy men [1]. They were injected beneath the skin over ten days, at 0.01–0.025 milligrams for every kilogram of a man's weight. Two of the three had darker skin within two weeks. They also had nausea, sleepiness and tiredness, and erections that lasted 1–5 hours. In 2005, Hadley wrote that those erections are what pointed researchers toward the sex-drive switch [18].
In 1998, Wessells reported the first erection trial, in 10 men [2]. Their doctors believed each man's erection trouble started in the mind rather than the body. On any given night, the men and staff alike were kept from knowing whether the shot was MT-II or a placebo, a dummy shot with no drug in it. The dose was 0.025 milligrams for every kilogram, given under the skin. Erections came in 8 of the 10 men. A band worn around the penis measured firmness: more than 80% firm for 38 minutes on MT-II, against 3 minutes on the placebo. The researchers judged a gap that size very unlikely to be chance. Nausea, yawning and a smaller appetite were common.
In 2000, a bigger trial took in 20 men [3]. Erections without any sexual touch came in 17 of the 20. Firmness above 80% lasted 41 minutes on average. Desire went up after 68% of MT-II shots and after 19% of placebo shots. Severe nausea followed 12.9% of shots at 0.025 milligrams for every kilogram.
You won't find a large final trial of MT-II in print. Bremelanotide, a drug your body makes when it breaks MT-II down, did get through those large trials, and the FDA approved it in 2019 for women troubled by low sexual desire. In 2022, a study of 31 such women took brain scans while they looked at sexual images [11]. On a drug aimed at the same switch, links between some brain areas changed, and desire rose for up to 24 hours. That backs up the route first spotted with MT-II.
What Melanotan 2 changes in sexual response
MT-II turns on the sex-drive switch in your brain. That switch sits in areas tied to desire. From there, nerve signals travel down and can produce an erection. Two of your body's chemical messengers, dopamine and oxytocin, carry part of that message.
Wessells ran the first controlled trial in people in 1998 [2]. His larger trial in 2000 also asked about desire. It rose after 68% of MT-II shots and after 19% of placebo shots [3]. Both trials used a band around the penis that measured swelling and firmness through the night.
The same effect can turn dangerous. When blood gets trapped and an erection refuses to subside, doctors call it priapism. In 2021, one such case followed an MT-II shot under the skin [10]. Medicines didn't end it, and surgeons had to drain the trapped blood. The paper called it only the third known case, which tells you how few reports exist. Damage can set in within hours.
If it happens to you, every hour counts.
What Melanotan 2 does to hunger and weight in animals
In rats and mice, MT-II did two things. At first the animals ate less. Over longer use, they stayed lighter, and their brown fat, a kind of fat that burns energy to make heat, ran hotter.
In 2017, Cote followed rats for 40 days [5]. Within 5 days they were eating their usual amount again. Even so, their weight stayed lower and the heat from brown fat went up 3-fold. Fat inside the belly dropped by 35–55%, so eating less can't explain all of it.
In 2022, Eliason put a tiny amount of MT-II, between 0.1 and 1 nanomole, into one brain area in mice [6]. For 1–4 hours they ate less and didn't try as hard for food. More drug gave a bigger effect. The mice didn't shun a taste paired with the drug, and their energy use held steady, so feeling ill is an unlikely reason.
In 2003, Raposinho tested MT-II in rats given NPY, a natural brain chemical that makes animals hungry [14]. MT-II stopped the overeating and fat gain that NPY caused. It did not undo what NPY did to two gland hormones: LH, which tells the body to make sex hormones, and growth hormone.
So in that test, you can see hunger and those hormones running on separate tracks.
What Melanotan 2 does not show about testosterone
Does MT-II raise or lower your testosterone? No study in people has shown either one. In 2003, Raposinho gave MT-II to rats [14]. It blocked the overeating caused by NPY, the hunger chemical. It didn't change the pulses of LH, the gland hormone that tells the testicles to make testosterone. That's a rat result, and it says nothing firm about your own testosterone. The Wessells trials in men never set out to measure it. If you hear that MT-II boosts testosterone, you'll find no published evidence behind the claim.
What Melanotan 2 may do to dopamine
Does MT-II raise dopamine, the brain chemical tied to your pleasure and drive? No human trial has measured it. In 2022, Thurston took brain scans while volunteers looked at sexual images [11]. A drug aimed at the sex-drive switch changed how brain areas for feeling and body sense linked up. That fits a role for dopamine and oxytocin, but it doesn't show you that MT-II raises dopamine in people. In 2017, Paiva gave MT-II to rats straight into a vein [15]. Brain cells that put out oxytocin, a bonding hormone, fired faster. Every direct dopamine check on MT-II so far comes from a few animal studies.
Melanotan 2 vs Melanotan 1: what each one changes
Melanotan 1 and Melanotan 2 grew out of the same idea. You'll find they are built differently, though, and they do different things.
MT-I (afamelanotide) is a straight 13-amino-acid chain. MT-II is shorter, a 7-amino-acid chain bent round into a ring. Being a ring makes MT-II harder for your body to take apart. Its short chain of 7 parts also grips its switches more tightly. MT-I acts mainly on the skin switch, so its main effect is skin color. MT-II also reaches the appetite, sex-drive and gland switches, which touch sex, hunger, body heat and your body's automatic work.
European regulators approved afamelanotide (MT-I) for a rare inherited condition in which daylight hurts the skin. That approval covers MT-I only. MT-II has no approval anywhere. Bremelanotide (PT-141) came out of work on how the body breaks MT-II down, and the FDA approved it in 2019 for women whose sexual desire is low. The page on Melanotan 2 vs Melanotan 1 structural differences shows you where their paths split.
What MT-II changed after a crushed nerve
In 2003, Ter Laak tested MT-II in rats after a nerve injury [13]. These were rats, not people like you. The rats got 20 micrograms for every kilogram of weight under the skin every 48 hours. After the large nerve in the leg had been crushed, feeling came back better in the treated rats. A second test found some protection against nerve damage from cisplatin, a cancer drug. Nobody knows why it helped. MT-II may act on Schwann cells, the cells that wrap and support your nerves. No human trial has tested MT-II for this kind of nerve repair.
What MT-II changed in blood sugar use
In 2005, Heijboer put MT-II into the brains of mice [12]. The total was 225 nanograms, an amount far too small for you to see, split into three doses over 24 hours. Afterward, insulin moved more sugar out of the blood and into muscle. The muscle cells also made more of the instructions for a protein that carries sugar inside. Body weight and food intake didn't change, and the liver's response to insulin stayed the same. The researchers think the brain switch sent the effect out to the body through nerves. This was in mice, and no human trial has tested it in people like you.